Debio 1453P: First-in-Human Safety Study

We are testing a new oral medication in healthy adults to see how safe it is and how the body processes it. This study aims to gather important information for future treatments.

6-12 monthsSafety phase (I)Infectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
SGS Belgium
SGS Belgium NV – Clinical Pharmacology Unit
Wilrijk, Belgium
Sponsor: Debiopharm International S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.